Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Alejandro O. Balbin"'
Autor:
Anna Kuchina, Lorena Espinar, Tolga Çağatay, Alejandro O Balbin, Fang Zhang, Alma Alvarado, Jordi Garcia‐Ojalvo, Gürol M Süel
Publikováno v:
Molecular Systems Biology, Vol 7, Iss 1, Pp 1-11 (2011)
Abstract Multipotent differentiation, where cells adopt one of several possible fates, occurs in diverse systems ranging from bacteria to mammals. This decision‐making process is driven by multiple differentiation programs that operate simultaneous
Externí odkaz:
https://doaj.org/article/37947b28a911456db7f4ad02a6f206f1
Autor:
Fang Zhang, Alma L. Alvarado, Alejandro O Balbin, Lorena Espinar, Anna Kuchina, Tolga Cagatay, Jordi Garcia-Ojalvo, Gürol M. Süel
Publikováno v:
Recercat. Dipósit de la Recerca de Catalunya
instname
Molecular Systems Biology
instname
Molecular Systems Biology
An important cell fate decision in Bacillus subtilis is shown to be the result of a ‘molecular race' between competing differentiation programs. The programs controlling competence initiation and spore formation progress independently, and without
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81a524d5995aa34d5e7538d8f59de621
http://hdl.handle.net/10230/25493
http://hdl.handle.net/10230/25493
Autor:
Xuhong Cao, Sunita Shankar, Anirban Sahu, Arul M. Chinnaiyan, Alejandro O. Balbin, John R. Prensner, Alexey I. Nesvizhskii, Mohan Saravana Dhanasekaran, Anastasia K. Yocum
Publikováno v:
Cancer Research. 73:5214-5214
Activating mutations in the Ras oncogenes characterize 20-40% of all non-small cell lung cancer (NSCLC), the leading cause of cancer mortality in the United States, which establishes Ras genes as the most commonly mutated oncogenes in this malignancy
Autor:
Mattew Iyer, Anirban Sahu, Alexey I. Nesvizhskii, Arul M. Chinnaiyan, Alejandro O. Balbin, Dan R. Robinson, Sunita Shankar, Anastasia K. Yocum, John Presner, Xuhong Cao, Mohan Saravana Dhanasekaran
Publikováno v:
Cancer Research. 72:LB-35
Lung cancer is the leading cause of cancer mortality in the United States, and non-small cell lung cancer (NSCLC) is the predominant subtype of this malignancy. Mutations in the KRAS oncogene characterize more than 20% of all NSCLC malignancies, and